Shares Tumble Despite Strong Q4

On May 14, 2026, Sharda Cropchem's shares dropped nearly 12% to an all-time low of ₹1,043.8. This significant fall occurred immediately after the company announced its Q4 FY26 financial results, which showed strong profit and revenue growth. The stock's decline, while the Nifty50 index rose 1.45%, signals that investors are focusing on concerns beyond the immediate financial performance.

Q4 Financial Performance

The company announced a significant 57% year-on-year jump in profit after tax (PAT) to ₹319 crore, compared to ₹204 crore a year ago. Revenue from operations rose 13% to ₹2,065 crore from ₹1,829 crore. This growth was driven by a 4.3% increase in agrochemical volumes and strong performance in Europe and Latin America. Earnings before interest, tax, depreciation, and amortisation (EBITDA) surged 75% to ₹513 crore, with margins expanding to 24.8%. For the full fiscal year FY26, revenue grew 22% to ₹5,268 crore, and PAT more than doubled, up 124% to ₹681 crore. The company achieved a record return on capital employed (ROCE) of 30.4% for FY26. Sharda Cropchem's board also proposed a final dividend of ₹9 per share, making the total ₹15 for FY26.

Valuation and Sector Headwinds Emerge

Despite strong financials and no debt, the stock's sharp drop suggests investors are worried about valuation or future growth. Sharda Cropchem's trailing P/E ratio of 15x-21x is lower than peers like PI Industries (33.48x), Bayer CropScience (29.86x), and UPL (28.31x). Its EV/EBITDA of 9.57x also suggests it's competitively valued. However, the market may have expected even stronger growth, which the current results couldn't fully support amid wider sector worries. The Indian agrochemical sector is expected to grow 6-8% in FY27, but faces challenges. Intense competition from China and global oversupply are pressuring prices. Geopolitical issues are causing volatile energy and logistics costs. China's removal of VAT export rebates on key materials also adds cost pressure for Indian companies. These broader issues seem to be affecting investor mood more than Sharda's specific performance.

Sustainability and Competition Risks

The stock's steep fall, even with good margins and ROCE, suggests investors doubt these can be maintained. Although management forecasts stable margins for FY27, competition and fluctuating input costs are risks. Sharda Cropchem's key export markets in Europe and Latin America could face slowdowns or new regulations. The company's reliance on international registrations, while good for its asset-light model, means it's exposed to changes in global market access and demand. China's VAT export rebate removal on key materials might also reduce the cost advantage for Indian companies if they can't pass on higher prices. Analyst price targets, averaging around ₹1,260.50, might not fully reflect these sector-wide issues or a possible market shift favoring less risky stocks.

Analyst Views and Future Outlook

Analysts generally remain positive, with a consensus 'Buy' rating and average 12-month price targets between ₹1,260.50 and ₹1,288.26, suggesting potential upside. However, the stock's recent fall indicates the market is weighing these future estimates against current economic and competition challenges. Management is confident, pointing to a strong registration pipeline and growing market presence. Sharda Cropchem's success in overcoming global supply chain issues, managing volatile input costs, and keeping its pricing power will be key to meeting growth goals and restoring investor trust.